[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU3938797A - Transdermal delivery of peptides - Google Patents

Transdermal delivery of peptides

Info

Publication number
AU3938797A
AU3938797A AU39387/97A AU3938797A AU3938797A AU 3938797 A AU3938797 A AU 3938797A AU 39387/97 A AU39387/97 A AU 39387/97A AU 3938797 A AU3938797 A AU 3938797A AU 3938797 A AU3938797 A AU 3938797A
Authority
AU
Australia
Prior art keywords
peptides
transdermal delivery
transdermal
delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU39387/97A
Inventor
Peter Hoengaard Andersen
Astrid Spillum
Helle Weibel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of AU3938797A publication Critical patent/AU3938797A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU39387/97A 1996-08-29 1997-08-26 Transdermal delivery of peptides Abandoned AU3938797A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK909/96 1996-08-29
DK90996 1996-08-29
PCT/DK1997/000346 WO1998008492A1 (en) 1996-08-29 1997-08-26 Transdermal delivery of peptides

Publications (1)

Publication Number Publication Date
AU3938797A true AU3938797A (en) 1998-03-19

Family

ID=8098895

Family Applications (1)

Application Number Title Priority Date Filing Date
AU39387/97A Abandoned AU3938797A (en) 1996-08-29 1997-08-26 Transdermal delivery of peptides

Country Status (3)

Country Link
AU (1) AU3938797A (en)
WO (1) WO1998008492A1 (en)
ZA (1) ZA977745B (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2205692A1 (en) * 1997-05-16 1998-11-16 Hyal Pharmaceutical Corporation Method of administration for a therapeutic agent utilizing suitable forms of hyaluronic acid and combinations with electroporation
US5882677A (en) * 1997-09-30 1999-03-16 Becton Dickinson And Company Iontophoretic patch with hydrogel reservoir
US6039977A (en) * 1997-12-09 2000-03-21 Alza Corporation Pharmaceutical hydrogel formulations, and associated drug delivery devices and methods
US7383084B2 (en) 2002-10-31 2008-06-03 Transpharma Medical Ltd. Transdermal delivery system for dried particulate or lyophilized medications
US7662404B2 (en) 2002-10-31 2010-02-16 Transpharma Medical Ltd. Transdermal delivery system for dried particulate or lyophilized peptides and polypeptides
IL152574A (en) 2002-10-31 2009-09-22 Transpharma Medical Ltd Transdermal delivery system for dried particulate or lyophilized medications
US8133505B2 (en) 2002-10-31 2012-03-13 Transpharma Medical Ltd. Transdermal delivery system for dried particulate or lyophilized medications
US8420605B2 (en) * 2005-09-07 2013-04-16 The University Of Strathclyde Hydrogel compositions
KR20080066712A (en) * 2005-09-30 2008-07-16 티티아이 엘뷰 가부시키가이샤 Functionalized microneedles transdermal drug delivery systems, devices, and methods
WO2008027218A2 (en) * 2006-08-29 2008-03-06 Alza Corporation Drug electrotransport with hydration measurement of hydratable reservoir
US7713937B2 (en) 2006-11-10 2010-05-11 Cara Therapeutics, Inc. Synthetic peptide amides and dimeric forms thereof
US7842662B2 (en) 2006-11-10 2010-11-30 Cara Therapeutics, Inc. Synthetic peptide amide dimers
US8906859B2 (en) 2006-11-10 2014-12-09 Cera Therapeutics, Inc. Uses of kappa opioid synthetic peptide amides
US8236766B2 (en) 2006-11-10 2012-08-07 Cara Therapeutics, Inc. Uses of synthetic peptide amides
AU2007317817B2 (en) 2006-11-10 2012-09-20 Cara Therapeutics, Inc. Synthetic peptide amides
EP2225226B1 (en) 2007-12-26 2016-08-17 Critical Outcome Technologies, Inc. Compounds and their use in a method for treatment of cancer
WO2010006438A1 (en) 2008-07-17 2010-01-21 Critical Outcome Technologies Inc. Thiosemicarbazone inhibitor compounds and cancer treatment methods
EP2552915B1 (en) 2010-04-01 2017-07-19 Critical Outcome Technologies Inc. Compounds for the treatment of hiv
US10342830B2 (en) 2015-01-05 2019-07-09 Gary M. Petrucci Methods and materials for treating lung disorders
US10993969B2 (en) 2016-02-05 2021-05-04 Gary M. Petrucci Methods and materials for treating nerve injuries and neurological disorders
US10478531B2 (en) 2017-06-22 2019-11-19 Gary M. Petrucci Methods and materials for treating blood vessels
US10251917B1 (en) 2017-09-19 2019-04-09 Gary M. Petrucci Methods and materials for treating tumors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA42747C2 (en) * 1993-12-23 2001-11-15 Ново Нордіск А/С Peptide derivatives, pharmaceutical composition and method for stimulating growth hormone releasing
AU711104B2 (en) * 1995-06-22 1999-10-07 Novo Nordisk A/S Compounds with growth hormone releasing properties

Also Published As

Publication number Publication date
ZA977745B (en) 1998-08-11
WO1998008492A1 (en) 1998-03-05

Similar Documents

Publication Publication Date Title
AUPO066096A0 (en) Oral delivery of peptides
AU3938797A (en) Transdermal delivery of peptides
AU7077098A (en) Transdermal delivery system
AU5159798A (en) Branched peptide linkers
AUPO203996A0 (en) Therapeutic uses
AU3640997A (en) Iontophoretic delivery of integrin inhibitors
AU2923697A (en) Transdermal contraceptive delivery system
AU3539297A (en) Transdermal therapeutic systems
AU2972097A (en) Peptide derivatives
AU2091799A (en) Uses of alpha-conotoxin peptides
AU1803597A (en) Peptide derivatives
AU4427296A (en) Novel peptide
AU4394396A (en) Modified peptides
AU2131195A (en) Prophenins - antibiotic peptides
AUPO026596A0 (en) Viral peptide
AU5095698A (en) Transdermal patch
AU1280701A (en) Iontophoretic transdermal delivery of peptides
AU5154498A (en) Peptides for gene delivery
AU5061698A (en) Peptide derivatives
AU5550296A (en) Conotoxin peptides
AU1999999A (en) Contryphan peptides
AU4636396A (en) Antiglucocorticoid medicament
AU4582597A (en) Therapeutic proteins
AU2316997A (en) Liposomal delivery system
AU5654096A (en) Antisense peptides